Scientists test 'Switchable' CAR-T cells to tame the Body's own immune attack
NCT ID NCT06913608
Summary
This early-stage study aimed to test a new two-part treatment for serious autoimmune diseases like lupus and scleroderma. The treatment involved collecting a patient's own immune cells (T cells), engineering them in a lab, and then infusing them back alongside a control drug. The main goals were to see if this combination was safe and if it could help control the diseases in patients who hadn't responded well to other treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS (SSC) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.